Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
The company that manufactures Airborne, described as a dietary supplement whose vitamins and minerals help support the immune system, has settled its case with the Federal Trade Commission over the advertising and labeling of its products.
According to the FTC, Airborne, Bonita Springs, Fla., “has agreed to pay up to $30 million to settle Federal Trade Commission charges that it did not have adequate evidence to support its advertising claims in which its effervescent tablet was marketed as a cold prevention and treatment remedy.”
Airborne
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in